Harm Reduction & Obstacles to Its Full Embrace – Detailed Study Notes

Overview of the Review Essay

  • Examines four recent book-length ethnographies on harm reduction, offering deep dives into diverse aspects of drug policy and practice:

    • Travis Lupick, Fighting for Space (Vancouver, 2018): Explores the establishment and cultural significance of North America's first supervised injection facility (SIF) in Vancouver.

    • Jarrett Zigon, A War on People (global anti–drug-war movement, 2019): Focuses on the transnational activism resisting the War on Drugs, emphasizing the affective bonds and experimental spaces created by activists.

    • Kimberly Sue, Getting Wrecked (women, incarceration, U.S. opioid crisis, 2019): Investigates the harmful intersection of criminal justice and substance use, particularly for women experiencing incarceration and opioid addiction in the U.S.

    • Nancy D. Campbell, OD: Naloxone and the Politics of Overdose (2020): Analyzes the complex role of Naloxone in addressing the opioid crisis, highlighting both its life-saving potential and the political barriers to its effective deployment.

  • Geographical breadth: The ethnographies collectively span various global contexts, from specific urban settings like Vancouver (Canada) and Copenhagen (Denmark) to broader carceral landscapes in Boston & Massachusetts prisons (U.S.) and national policy shifts in Scotland & UK prisons. This wide scope allows for comparative insights into different approaches to harm reduction.

  • Central aim: The review essay aims to illuminate why, despite compelling scientific and empirical evidence demonstrating the effectiveness and benefits of harm-reduction logics, many societies—especially in North America—have been slow or resistant to fully embrace and implement these approaches on a wider scale.

  • Overarching metaphor: Campbell's concept of the “North American disaster,” characterized by ongoing punitive drug policies and high overdose rates, is contrasted with Lupick's idea of “spaces of comfort,” referring to harm reduction sites like Insite that provide respite and care for drug users.

  • Methodological variety: The books showcase diverse ethnographic approaches:

    • Journalistic ethnography (Lupick): Combines rigorous reporting with immersive fieldwork.

    • Assemblage/“assemblic” ethnography (Zigon): Traces the dynamic connections and relationships between people, places, and ideas across various sites, rather than focusing on a single, bounded location.

    • Carceral ethnography (Sue): Conducts fieldwork within prisons and jails to understand the lived experiences of incarcerated individuals and the impact of punitive systems.

    • Science-studies approach to a pharmaceutical (Campbell): Examines a specific scientific intervention (Naloxone) within its broader social, political, and historical contexts.

Harm Reduction: Definition & Key Principles

  • Core definition (Harm Reduction International): Harm reduction encompasses strategies designed to “minimise negative health, social and legal impacts associated with drug use, drug policies and drug laws.” This means focusing on reducing the harms of drug use itself (e.g., overdose, disease transmission), as well as the harms caused by punitive drug policies (e.g., incarceration, stigmatization).

  • Acknowledges inevitability of drug use; abstinence is not always realistic or desirable: Unlike traditional abstinence-only approaches, harm reduction recognizes that many people use drugs for various reasons, and complete abstinence might not be achievable or preferred for everyone. The goal shifts from stopping all drug use to making drug use safer and reducing associated risks.

  • Re-centres agency, wellbeing, empowerment, and “letting-be.”: This principle emphasizes respecting the autonomy of individuals who use drugs, empowering them to make informed choices, and fostering their overall wellbeing. "Letting-be" implies a non-judgmental stance, allowing individuals to exist and seek care without coercion.

  • Canonical tools & practices: These are evidence-based interventions widely implemented in harm reduction programs:

    • Needle & syringe programmes (NSPs): Provide sterile injection equipment to prevent the transmission of blood-borne diseases like HIV and hepatitis C.

    • Safe / supervised injection facilities (SIFs): Legally sanctioned and medically supervised sites where individuals can inject pre-obtained drugs in a safer environment, reducing overdose risk and providing access to health services.

    • Opioid substitution therapies (e.g., methadone, buprenorphine): Medications that reduce cravings and withdrawal symptoms, providing a stable alternative to illicit opioid use and improving health outcomes.

    • Naloxone distribution & training: Naloxone is an opioid overdose reversal medication; distributing it widely and training people to use it saves lives during overdose emergencies.

    • Peer-run drug-user unions (e.g., VANDU - Vancouver Area Network of Drug Users): Organizations led by people who use drugs, advocating for their rights, providing services, and fostering community support.

  • Documented macro-level benefits: Studies consistently show significant public health and economic advantages of harm reduction:

    • Reduced infectious-disease transmission (e.g., HIV, HCV) among people who inject drugs.

    • Lower overdose mortality rates due to SIFs and Naloxone distribution.

    • Cost savings for health-care and law-enforcement systems, as harm reduction is often more cost-effective than managing the consequences of untreated addiction and incarceration (Boyd 2013; Kinnard et al. 2014; Kral & Davidson 2017).

Historical & Political Context

  • Modern “War on Drugs” launched by U.S. President Richard Nixon in 1971: This initiative declared drugs “public enemy number one,” marking a significant shift from a public health approach to a criminal justice-centered, punitive strategy that led to mass incarceration and stigmatization of drug users.

  • Ongoing punitive policies: The legacy of the War on Drugs continues through widespread carceral expansion, heightened stigmatization of people who use drugs, and the emergence of what Sue terms a “carceral-therapeutic state,” where the criminal justice system increasingly attempts to manage addiction, often through coercive and ineffective means.

  • Paradigm tension: There is a constant conflict between the medical / public-health framing of drug use as a health issue requiring treatment and support, versus the criminal-legal framing that views drug use primarily as a moral failing or criminal act deserving punishment. This tension profoundly shapes policy debates and implementation.

  • Global disparities: While countries like Switzerland, the Netherlands, and Germany adopted harm-reduction policies relatively early and successfully integrated them into public health frameworks, significant resistance persists in the U.S. and Canada, despite evidence of local successes and a severe opioid crisis. This resistance is often rooted in political ideology, moralistic views, and punitive cultural norms.

Case Study 1 – Vancouver & Fighting for Space

  • Insite (opened 2003) = North America’s first sanctioned SIF: Its establishment was a groundbreaking achievement, providing a safe, hygienic, and supervised environment for injection drug users in Vancouver's Downtown Eastside, a neighborhood disproportionately affected by drug use and associated harms.

  • Built through ≈20 years of activism by VANDU, health professionals, and policymakers: The creation of Insite was the culmination of decades of sustained grassroots advocacy from drug user unions (like VANDU), persistent efforts by public health officials, and eventual political will, demonstrating the power of inter-sectoral collaboration and community organizing.

  • Supreme Court of Canada ruling: In 2011, the Supreme Court of Canada ruled that addiction should be classified as an illness, thereby granting constitutional protection for Insite and safeguarding its existence against political challenges. This landmark decision recognized the health imperative of harm reduction.

  • Cultural dimension: Beyond its medical function, users describe Insite as a “space to live in the greatest degree of comfort”—more than a clinic, it operates as an oasis, offering a sense of community, dignity, and belonging that is often absent in the lives of heavily stigmatized individuals.

  • Dual foundation of success:

    1. Medical framing (“brain disease model,” Volkow, Koob & McLellan 2016): This framework, which posits addiction as a chronic brain disease, provided legitimization and scientific backing for Insite, essential for its legal and political acceptance.

    2. Community ethos of accommodation and radical hospitality: Insite's success is equally rooted in its commitment to welcoming and supporting drug users without judgment, fostering a sense of safety and community that encourages engagement with services and reduces isolation.

Case Study 2 – Global Anti-Drug-War Movement & A War on People

  • Method: “assemblic ethnography” → Zigon's innovative approach tracks dynamic relationships and emerging phenomena across multiple sites rather than focusing on a single, fixed location. This allows for an understanding of how global movements coalesce and adapt.

  • Key concepts:

    • “Dying-with”: This concept describes the shared grief and collective mourning over overdose deaths experienced by activists and communities affected by the drug war. This shared affective experience acts as a powerful glue for collective action and solidarity.

    • “Disclosive freedom”: Refers to a radical openness and vulnerability where activists and drug users disclose their experiences without fear of judgment, fostering an environment that welcomes even those labeled “non-human addict outsiders” by dominant society.

    • “Clearings”: These are experimental zones or temporary spaces (physical or conceptual) where people practice new forms of being-together, challenging existing norms and envisioning alternative futures free from the violence of the drug war. Examples include activist meetings, harm reduction sites, or informal gatherings.

  • Empirical arenas: Zigon's ethnography spans diverse settings, including Copenhagen SIFs (exploring their daily operations and user experiences), Vancouver’s Downtown Eastside networks (observing community organizing and mutual aid), and transnational policy forums (analyzing global advocacy efforts and diplomatic engagements).

  • Theoretical project: Zigon’s work embodies an anthropology attentive to the “not-yet,” meaning it focuses on emergent possibilities, alternative ways of living, and the collective efforts to sustain hope for future worlds where punitive drug policies are dismantled and replaced by more humane approaches.

Case Study 3 – Women, Carcerality & Getting Wrecked

  • Fieldwork in Boston-area jails/prisons & community programs: Sue's research provides an intimate look at the experiences of women navigating the U.S. criminal justice system and the opioid crisis.

  • Concept: “carceral-therapeutic state.”

    • Since the 1960s, elements of treatment and punishment have increasingly merged within the criminal justice system. Jails, rather than being solely punitive, now often act as “moral enforcement” sites, imposing abstinence and behavioral control under the guise of therapy.

    • Prevailing ideology: A strict total abstinence ideology dominates within these carceral settings, leading to forced “cold-turkey” withdrawal, often without medical supervision, despite overwhelming evidence supporting the efficacy of opioid substitution therapies like methadone and buprenorphine in managing withdrawal and preventing relapse.

  • Observed consequences:

    • Acute, untreated withdrawal: Women in jails and prisons often suffer severe and unmanaged withdrawal symptoms, which are intensely painful and can be dangerous.

    • Elevated post-release overdose risk: After release, individuals who have undergone forced detoxification are at a significantly higher risk of fatal overdose due to lowered opioid tolerance.

    • Social & civil death post-incarceration: Prison sentences lead to ruptured employment opportunities, unstable housing, and strained family ties, effectively creating a

Yes, the article directly addresses why stigma and controversy may still exist surrounding harm reduction programs and facilities, particularly in North America. It highlights several key factors:

  1. Legacy of the "War on Drugs": The modern "War on Drugs" launched in 1971 by U.S. President Richard Nixon shifted drug use from a public health issue to a criminal justice one. This led to widespread punitive policies, mass incarceration, and heightened stigmatization of drug users, which continues to impact public perception today.

  2. Paradigm Tension: There's an ongoing conflict between viewing drug use as a medical/public-health issue requiring treatment and support versus a criminal-legal issue seen as a moral failing or criminal act deserving punishment. This fundamental disagreement fuels controversy over harm reduction, which aligns with the public health model.

  3. Political Ideology, Moralistic Views, and Punitive Cultural Norms: The note explicitly states that resistance to harm reduction, especially in the U.S. and Canada, is "often rooted in political ideology, moralistic views, and punitive cultural norms." This suggests that societal values and political stances prioritize punishment and abstinence over pragmatic harm reduction strategies.

  4. "Carceral-Therapeutic State" and Abstinence Ideology: Within the criminal justice system (as explored in Kimberly Sue's Getting Wrecked), there's a merging of treatment and punishment in what's termed a "carceral-therapeutic state." Jails become "moral enforcement" sites that impose strict "total abstinence" ideologies, often through coercive and medically unsupervised methods. This reinforces the idea that drug use is a moral failing requiring forced sobriety rather than a health condition requiring compassionate care, thus contributing to stigma and controversy.